Men's Health News

RSS

Age exacerbates COVID neuroimmunological symptoms

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Illinois at Chicago investigated whether aging exacerbated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced neuropsychiatric disorders.

6 Jun 2022

Physical activity and long COVID symptoms

In a recent study posted to the medRxiv* preprint server, researchers evaluated associations between physical activity and long coronavirus disease (COVID) symptoms.

6 Jun 2022

Height increases risk of certain diseases

In a recent study published in the Journal PLoS Genetics, researchers investigated how height determined several common clinical traits in adults by comparing associations of those traits with actual- and genetically-predicted-height.

5 Jun 2022

Survey: Two-thirds of men believe they are naturally healthier than others

We all know we should eat well and exercise to stay healthy, but a new national survey conducted online by The Harris Poll on behalf of Orlando Health finds an alarming number of men might be skipping a simple yet critical step in a healthy lifestyle: an annual checkup with their doctor.

2 Jun 2022

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

Inviting people who don't have symptoms to be screened for prostate cancer is not currently recommended and should be approached with caution because, for most men, the benefit is small and uncertain and there are clear harms, warn experts in The BMJ today.

1 Jun 2022

New research shows how fathering can have lasting effects across generations

University of Notre Dame Associate Professor of Anthropology Lee Gettler and his collaborators have drawn on data collected over more than 30 years from almost 1,000 men in the Philippines to help shed light on the importance of adolescence and father-son experiences to sons' adult testosterone patterns.

31 May 2022

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies, according to a study published in the Journal of Clinical Oncology.

31 May 2022

Discovery of new prostate cancer subtype opens the door to development of therapies

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.

27 May 2022

Combined treatment approach proves to be beneficial for prostate cancer patients

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy - a commonly used hormone injection - plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.

26 May 2022

Why gyms have a higher risk of COVID

Researchers discuss the marked change in aerosol emission over a range of physical exercises.

26 May 2022

Study shows glomerulonephritis after SARS-CoV-2 mRNA vaccination likely coincidental

In a recent study posted to the medRxiv* pre-print server, researchers assessed whether messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines increase the incidence of glomerulonephritis against the null hypothesis stating any observed temporal association between the two phenomena was purely coincidental.

26 May 2022

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients who were only receiving hormone therapy, Michigan Medicine researchers found.

25 May 2022

The root causes of long-COVID still a mystery

In a recent article posted to the journal Annals of Internal Medicine, researchers presented baseline outcomes from a longitudinal assessment of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), also known as long-COVID.

25 May 2022

Correlation between long-COVID and physical inactivity

In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers assessed whether physical inactivity in coronavirus disease 2019 (COVID-19) survivors led to the development of post-acute sequelae of COVID-19 (PASC), also known as long-COVID.

25 May 2022

Largest study to date on long COVID identifies a broad list of diagnoses

Researchers characterize post-acute sequelae of SARS-CoV-2 infection.

25 May 2022

Factors affecting exercise during COVID-19 pandemic

Researchers identify the barriers and facilitators to PA during the COVID-19 pandemic across different demographic groups.

24 May 2022

Sustained weight loss can help improve semen quality in men with obesity

Men all over the world are suffering from deteriorating semen quality – often referred to as an outright fertility crisis.

23 May 2022

Largest study to date on the effect of vaccination on long-COVID

In a recent study published in the British Medical Journal, researchers evaluated the association between coronavirus disease 2019 (COVID-19) vaccination and long COVID symptoms among adults residing in United Kingdom (UK) communities with positive COVID-19 history before vaccination.

23 May 2022

The enigma of post-acute infection syndromes

In a recent review published in the journal Nature Medicine, researchers summarized known literature findings of the unexplained post-acute infection syndromes (PAISs).

20 May 2022

Natural immunity weak and short-lived in unvaccinated after Omicron infection

In a recent study posted to the journal Nature, researchers showed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infection without SARS-CoV-2 vaccination conferred poor cross-variant neutralizing capacities.

20 May 2022